Primary stage: The initial yaws lesion develops
at the inoculation site.
2. Secondary stage: Widespread dissemination of treponemes results in multiple skin lesions similar to the primary yaws lesion.
3. Latent stage: Symptoms are usually absent, but skin lesions can relapse.
4. Tertiary stage: Bone, joint, and soft tissue deformities may occur.
Children of preschool and school going (under 15 years) are the main yaws victims, with peak incidence in the six-to ten-year-old age range. Treatment of earlystage yaws is very simple and inexpensive. Re-infection or relapse leading to recurrence is rare. An estimated 50-100 million persons were infected before mass treatment campaigns in the 1950s. In the 1970s, yaws cases declined to fewer than 2 million. In the 1980s, fewer than 500 cases per year were reported in the Western Hemisphere. A resurgence of yaws has occurred in West and Central Africa, Southeast Asia, and the Pacific Islands, with recent outbreaks in Thailand, India, Indonesia, Papua New Guinea, and the Solomon Islands. Sporadic cases are reported in South America. In 1995, WHO estimated the number of infectious cases to be 460 000 worldwide of which, 400 000 were in west and central Africa, 50000 in South-East Asia and the rest in other tropical regions. 9
Eradication: Early Attempts, Failure, and Lessons: Between 1952 and 1964, WHO and the United Nations Children's Fund (UNICEF) led a worldwide campaign to control and eventually eradicate yaws and other endemic treponematoses. 10 This was a major disease control effort undertaken by WHO just after its establishment in 1948. 11 Control programmes were established in 46 countries and, by the end of 1964, the number of cases had been reduced from 50 million to 2.5 million (a 95% reduction). 12 The yaws control efforts paved the way for the development of the primary health care system in affected areas. 13 In the late 1960s, there was a shift in strategy from the vertical programme to integration of yaws surveillance and control into primary health care to tackle the remaining 5% of cases. However, this approach did not succeed.By the end of the 1970s, reemergence of yaws in many countries prompted a World Health Assembly Resolution requesting the implementation of integrated treponematoses control programmes. 14 Renewed control efforts were implemented in several countries, e.g. Benin, Burkina Faso, Côte d'Ivoire, Ghana, Mali, the Niger and Togo, but these efforts were not sustained. In 1984, a global meeting was organized in Washington, DC followed by regional meetings with the aim of reviving eradication activities. 15 These attempts were half-hearted and the goal of eradication remained elusive. 16 At this time, most of the yaws programmes had been integrated into primary health care which were generally too weak to implement the activities of a vertical programme. 17 Since then, yaws has remained as a public health problem in a few pockets, including three countries in the SEA Region -India ,Indonesia and Timor-Leste. The South-East Asia Region of WHO kept yaws high on its agenda and set the goal of regional eradication by 2012 in its two remaining endemic countries -Indonesia and Timor-Leste after India achieved elimination.
The yaws eradication is possible as there are factors which is always amenable to take care of:
• Man is the principal reservoir 
Issues and challenges:
''Some of the issues and challenges that have hampered yaws eradication historically include the lack of an effective mechanism for surveillance and case detection, limited political commitment and resources, limited capacity of general health staff to recognize and treat yaws, ensuring drug supply and logistics management, creating community awareness through appropriate advocacy /IEC [Information, Education, and Communication] campaigns and extending the services to remote and hard to reach areas,'' a recent WHO report remarked. 10 ''Unfortunately, yaws remains among the most neglected diseases and there is little global attention or focus on this disease. The World Health Organization should publicize the currently known and unknown status of surveillance for this disease in each of the remaining suspected endemic countries, and encourage mapping and more detailed reporting of surveillance data'' 19 In a consultation round-up held recently at the organization's headquarters in Geneva, basic agenda for future action was undertaken. 20 The agenda includes a rapid assessment of the burden of disease and infection in selected countries; revival of activities to control yaws; and establishment of an elimination program for yaws, directed by WHO in the context of its larger Neglected Tropical Diseases initiative. Elimination of clinical cases (zero cases) supported by active case-finding and serological surveys has been declared as the goal, but no timeline has been set. Although it is generally agreed that political and financial inertia are the biggest obstacles to interrupting transmission of yaws, some eradication experts point out that biological and medical barriers also exist. For example, although it is usually claimed that humans are the only reservoir of infection, 17% of the members of a wild gorilla population in the Republic of Congo presented typical yaws skin lesions. 21 Yaws may also affect African baboons, and widespread serological testing of wild populations has been performed; genetic analyses of a strain collected from a Guinean baboon shows that it is closely related to human yaws strains. 22 If complete eradication is to be enforced, nonhuman reservoirs need to be cleared as well. Successful treatment campaigns have already been carried out on primates against various infectious diseases; in the case of yaws, affected baboons were darted and treated with penicillin and an additional antibiotic. 23 In parallel, more information is needed on the way pathogens cross transmit between humans and primate populations, so that suitable strategies to prevent disease spreading and/or resurgence may be developed. As for humans, untreated victims may remain infective for months, favoring the spread of treponemes within populations. A vaccine is still lacking, and so is a reliable test able to distinguish yaws from the various other treponematoses and monitor its impact on populations, as discussed earlier. Furthermore, some researchers noted, the recurrent shortage of benzathine penicillin G in North America due to production problems could make mass treatment difficult. 24
Research priorities:
We still do not fully understand the epidemiology of yaws in non-human primates, the relationship between transmission intensity, cross transmission between human and non human primates, disease pattern, and severity of the disease and subsequent complications. There is lack of rapid diagnostic test especially in early lesions. We still need to know more insights on the effect of mass treatment compared with targeted treatment, given the cost of the medication.
Diagnostic dilemma and surveillance
The lack of reliable serological or morphological tests to distinguish T. pallidum subspecies obviously limits diagnostic accuracy, which can have serious detrimental effects. For example, treatment for a pregnant woman with burntout yaws and one with active syphilis should be different, and assigning the wrong treatment may result in a negative outcome.
Focus of research:
• In-depth analysis of the T. pallidum genome, in the attempt to identify and decipher determinants of host specificity, pathogenicity, and virulence among the different subspecies
• Research on DNA polymorphisms may lead to serological tests that could be used in the field, facilitating disease control and eradication efforts by permitting the monitoring of its continued impact on populations
• Active and passive surveillance with integrity need to be addressed before eradication policy in process.
Treatment of preschool children
In Timor-Leste, the health care workers engaged in immunization campaigns have reported clinical yaws among 1%-2% of children below five, during 2003-2006,There is increasing evidence that preschool children would benefit from treatment even though their burden of infection may not be as high as that in other age groups. Yaws infection can lead to impairment of vaccine development leading to persistent infection of same or other infectious disease.
Focus of research:
• Injection of penicillin of preschool children is painful and frightening; health systems research for effective delivery of alternating drugs in combination with other nutritional supplement through community-based organizations should be carried out.
• More studies are required to confirm the adverse effects of yaws on children <5 years of age and the safety of alternating drugs in children <5 years of age. Based on the findings of these research studies, strategies could be developed for yaws eradication children <5 years of age.
Improving the interventions with penicillin among school-age children
In yaws, the occurrence of disease is directly related to the intensity of infection and is highest in schoolage children. In young children, intimate contact is highest at school activity especially in poor hygienic children. Regular and intensified injection of penicillin using the school infrastructure and schoolteachers is one of the strategies. Some countries in the Region have shown a good reduction in infection rates following mass eradication programme through penicillin shots. The ongoing programmes needs to be sustainable, ensured and impact should be evaluated.
Focus of research:
• Impact assessment of eradication of yaws programmes on the prevention of reinfection.
• Identification of sustained, effective interventions through community mobilization and partnerships
• Operational research along with an intervention programme among non-enrolled schoolchildren. These children are risky, infectious , reservoirs and amenable to sustain infection in community.
Improving the personal hygiene and environmental changes:
In general, poor hygienic conditions favor the transmission of yaws through contact with skin contact and secretions from lesion. Bites, excoriation, injury is the easy method for quick transmission. Studies need to be carried out to identify the specific components of hygienic conditions associated with a higher risk of yaws.
Focus of research:
• Estimation of the frequency and improving cleanliness, personal hygiene and environmental sanitation among schoolchildren and the community.
• Motivating community efforts to reduce transmission through hygiene or reduction of other maneuver.
• Environmental control of flies with intervention of vector bionomics and control strategy needs to address.
• Review and assessment of the current coverage of SAFE strategy and suggestions for improving the strategy at community level.
Improvement of drug safety
Women of childbearing age are among the most atrisk groups. Although penicillin is safe in pregnancy, there is always fear to use injection penicillin in immuno-altered status, as there is chance of hypersensitivity. Alternating drugs are not also very safe like tetracycline and doxycycline.
Focus of research:
• Absolute safe status of Penicillin is to be ensued
• Erythromycin/azithromycin as alternative should also be evaluated for absolute safety with easy way of administration
• New alternating drugs need to be identified for easy and effective administration.
Monitoring drug efficacy and early detection of drug resistance
The rate of post-treatment reinfection and relapse need to be addressed and the efficacy of Penicillin should be monitored regularly as efficacy diminishes with frequent and periodic use. As a result, there are justifiable concerns about the possibility of emerging resistance, which is now common for Penicillin in other bacterial infection. Also its efficacy, safety, adversity, resistance in primates should also be addressed. Effective monitoring of large scale eradication programme need to be built.
Focus of research:
• Develop new drugs, and evaluate the efficacy and safety of available drugs in human and non-human primates.
• Identification of sensitive and resistance genes in populations is to be known. Sensitive molecular tools to monitor drug efficacy need to be developed.
• Strategy to develop vaccines.
• Clinical trials for the development of vaccines against yaws and collaboration between research and eradication programme should be priority. 
